Drug Profile
CRX 150
Alternative Names: Amoxapine/dipyridamole; CRx-150; Dipyridamole/amoxapineLatest Information Update: 02 Jul 2007
Price :
$50
*
At a glance
- Originator CombinatoRx
- Class Anti-inflammatories; Anti-ischaemics; Antiplatelets; Antirheumatics; Chemoprotectants; Dibenzoxazepines; Ischaemic heart disorder therapies; Piperazines; Pyrimidines; Tricyclic antidepressants; Vasodilators
- Mechanism of Action Cytokine modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Periodontal disorders; Rheumatoid arthritis
Most Recent Events
- 02 Jul 2007 Interim results from a phase II clinical trial in patients with rheumatoid arthritis added to the adverse events and Rheumatic Disease therapeutic trials sections
- 29 Jun 2007 Discontinued - Phase-II for Periodontal disorders in Estonia (PO)
- 29 Jun 2007 Discontinued - Phase-II for Periodontal disorders in Norway (PO)